As a knowledge-based company, Parand Darou Pharmaceutical began its operations in 2006 with the production of both narcotic and non-narcotic Active Pharmaceutical Ingredients (APIs), including Codeine Phosphate, Noscapine, Thebaine, Papaverine, and Oxycodone. The company became the second private-sector enterprise in Iran to obtain a narcotic production license from the Iran Food and Drug Organization, highlighting its credibility and compliance with strict regulations. In addition to fulfilling the domestic market’s needs, Parand Darou successfully expanded its presence in global markets, exporting high-quality products and establishing itself as a reliable partner in the international pharmaceutical industry.    
⇒ Read More